✦ LIBER ✦

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

✍ Scribed by Giovanna Fattovich; Lucio Brollo; Alfredo Alberti; Patrizia Pontisso; Giuliano Giustina; Giuseppe Realdi

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 444 KB
Volume: 8
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840080630

No coin nor oath required. For personal study only.

✦ Synopsis

Twenty-eight patients with chronic active hepatitis without cirrhosis who were positive for hepatitis B surface antigen and antibody to hepatitis B e antigen were followed for 1 to 15 years (mean 6.6 years) and underwent follow-up biopsy. At presentation, 12 of the 28 patients (43%) had hepatitis B virus DNA in serum, 10

📜 SIMILAR VOLUMES

Long-term follow-up of peginterferon and

Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B

✍ Henry Lik-Yuen Chan; Alex Yui Hui; Vincent Wai-Sun Wong; Angel Mei-Ling Chim; Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

We have previously demonstrated that combination peginterferon and lamivudine treatment has superior antiviral efficacy to lamivudine monotherapy in chronic hepatitis B. In this study, we investigated the long-term posttreatment virological response to this combination treatment. Sustained virologic

Long-term follow-up of antimitochondrial

Long-term follow-up of antimitochondrial antibody–positive autoimmune hepatitis

✍ Conor O'Brien; Supriya Joshi; Jordan J. Feld; Maha Guindi; Hans P. Dienes; E. Je 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 1 views

Antimitochondrial antibodies (AMAs) are the serological hallmark for primary biliary cirrhosis (PBC). When AMAs are detected in patients with chronic hepatitis, they negatively impact on the autoimmune hepatitis (AIH) scoring system. The purpose of this study was to determine if AMAs detected in the

Long-term follow-up of alpha-interferon

Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B

✍ Monika van Zonneveld; Pieter Honkoop; Bettina E. Hansen; Hubertus G.M. Niesters; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Long-term follow-up of hepatitis B virus

Long-term follow-up of hepatitis B virus carrier infants

✍ Cho-Yu Chan; Shou-Dong Lee; May-Ing Yu; Yuan-Jen Wang; Yang-Te Tsai; Kwang-Juei 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 1 views

## Abstract One hundred twenty‐two hepatitis B surface antigen (HBsAg) carrier infants were followed‐up for 8–10 years. One hundred eleven had antibody to hepatitis B core antigen (anti‐HBc; 83 had been vaccinated) and the remaining 11 were without anti‐HBc (7 had been vaccinated). During the follo

Semiquantitative anti-HBc IgM detection

Semiquantitative anti-HBc IgM detection in children with chronic hepatitis B: A long-term follow-up study

✍ G. B. Gaeta; S. Nardiello; T. Pizzella; G. Russo; A. Maisto; C. Sardaro; B. Gala 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

## Abstract Serum anti‐HBc IgM titres were monitored monthly by a semiquantitative method in 14 children with HBeAg positive chronic hepatitis B followed up for 18‐65 months. All patients, but one, were treated with alfa‐interferon (IFN) at different times. On the whole, 12 flare‐up episodes were o

Long-term follow-up of patients with chr

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

✍ Michiko Shindo; Adrian M. di Bisceglie; Jay H. Hoofnagle 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986